Published :
Tables : 49
Figures : 44
Category : Healthcare
No. of Pages : 226
Report Code : HC-U3271
Compression Therapy Market is poised to value USD 4316.15 million by 2028 end at a CAGR of 5.2% during the forecast period 2022 to 2028. The rising occurrence of vein diseases like deep vein thrombosis, leg ulcers, varicose veins, blood clots and lymphedema and the increased usage of bandages and stockings for treating these vein diseases are some factors driving the compression therapy market growth. Applying these products reduce the foot and leg volume, hypertension and venous flex which shall boost the market growth further. The rising geriatric population coupled with the increasing number of orthopedic surgeries with a rise in accident cases and the number of obese people has propelled the growth of the market. As per the American Academy of Orthopedic Surgeons, 2006, hip and knee replacements are anticipated to rise by over 170% and 670% respectively over the next 20 years. Additionally, compression garments are used to treat sport related injuries in preventing swelling and inflammation post the trauma or injury. These products are prominently used for increasing the body’s blood circulation, thereby helping in maintaining muscle health. Market Segmentation: By Technique • Static Compression Therapy • Dynamic Compression Therapy By Product • Compression Pumps • Compression Garments o Compression Stockings o Compression Bandages & Wraps o Other Compression Garments*(foot caps, arm sleeves, gauntlets, compression shirts and bras, chin straps, face masks, and abdominal gloves) • Compression Braces By Application • Varicose Vein Treatment • Deep Vein Thrombosis Treatment • Lymphedema Treatment • Leg Ulcer Treatment • Other Applications**(the use of compression therapy during traveling, pregnancy, foot ulcers, and leg pain) By Distribution Channel • Pharmacies & Retailers • Hospitals & Clinics • E-Commerce Platforms By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is classified into technique, product, application, distribution channel and region. The Technique segment is categorised into static compression therapy and dynamic compression therapy. The static compression therapy segment is user friendly and is highly convenient and it is greatly accessible for treating sports-related injuries and oedema for relieving pressure and pain. Furthermore, it is used for treating dep vein thrombosis, chronic venous insufficiency and lymphedema which is prominently observed in geriatric and diabetic population. For example, according to the National Medical Policy of Health Net Inc. recommended using intractable lymphedema in arms owing to mastectomy. Such factors shall boost the segment growth substantially. The product segment id categorised into pumps, stockings, bandages and tapes. The bandages segment is anticipated to hold the largest compression therapy market share owing to their increased acceptance in treating oedema, lymphatic and venous diseases of the lower limb. Advantages like high cost efficiency, high tension susceptibility elasticity and extensibility related to bandages shall boost the proliferation of the market. Regional Analysis: The North America region is predicted to lead the market owing to the rise in the geriatric population and increased prevalence of appalling venous diseases along with rising obesity, increased disposable income and a strong presence of pharmaceutical and biopharmaceutical companies in the region. As per the report provided by the NCBI, the incidence of appalling venous diseases was prominent in western nations with over 35% in females and over 16% in males. Competitive Landscape: • Medi GmbH & Co. • Paul Hartmann AG • Julius Zorn GmbH • ArjoHuntleigh • Sigvaris • Medtronic Plc • BSN Medical GmbH. • DJO Global, Inc. • Tactile Medical • Sanyleg S.r.l. • 3M Company • ConvaTec Inc. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global compression therapy market by technique, by product, by application, by distribution channel and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Market Segmentation:
By Technique • Static Compression Therapy • Dynamic Compression Therapy By Product • Compression Pumps • Compression Garments o Compression Stockings o Compression Bandages & Wraps o Other Compression Garments*(foot caps, arm sleeves, gauntlets, compression shirts and bras, chin straps, face masks, and abdominal gloves) • Compression Braces By Application • Varicose Vein Treatment • Deep Vein Thrombosis Treatment • Lymphedema Treatment • Leg Ulcer Treatment • Other Applications**(the use of compression therapy during traveling, pregnancy, foot ulcers, and leg pain) By Distribution Channel • Pharmacies & Retailers • Hospitals & Clinics • E-Commerce Platforms By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is classified into technique, product, application, distribution channel and region. The Technique segment is categorised into static compression therapy and dynamic compression therapy. The static compression therapy segment is user friendly and is highly convenient and it is greatly accessible for treating sports-related injuries and oedema for relieving pressure and pain. Furthermore, it is used for treating dep vein thrombosis, chronic venous insufficiency and lymphedema which is prominently observed in geriatric and diabetic population. For example, according to the National Medical Policy of Health Net Inc. recommended using intractable lymphedema in arms owing to mastectomy. Such factors shall boost the segment growth substantially. The product segment id categorised into pumps, stockings, bandages and tapes. The bandages segment is anticipated to hold the largest compression therapy market share owing to their increased acceptance in treating oedema, lymphatic and venous diseases of the lower limb. Advantages like high cost efficiency, high tension susceptibility elasticity and extensibility related to bandages shall boost the proliferation of the market.
Regional Analysis:
The North America region is predicted to lead the market owing to the rise in the geriatric population and increased prevalence of appalling venous diseases along with rising obesity, increased disposable income and a strong presence of pharmaceutical and biopharmaceutical companies in the region. As per the report provided by the NCBI, the incidence of appalling venous diseases was prominent in western nations with over 35% in females and over 16% in males.
Competitive Landscape: • Medi GmbH & Co. • Paul Hartmann AG • Julius Zorn GmbH • ArjoHuntleigh • Sigvaris • Medtronic Plc • BSN Medical GmbH. • DJO Global, Inc. • Tactile Medical • Sanyleg S.r.l. • 3M Company • ConvaTec Inc.
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the global compression therapy market by technique, by product, by application, by distribution channel and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Compression Therapy Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Compression Therapy Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Compression Therapy Market Analysis tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Compression Therapy Market, By Technique Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 7.1. Static Compression Therapy 7.2. Dynamic Compression Therapy 8. Compression Therapy Market, By Product Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 8.1. Compression Pumps 8.2. Compression Garments 8.2.1. Compression Stockings 8.2.3. Compression Bandages & Wraps 8.2.4. Other Compression Garments*(foot caps, arm sleeves, gauntlets, compression shirts and bras, chin straps, face masks, and abdominal gloves) 8.3. Compression Braces 9. Compression Therapy Market, By Application Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 9.1. Varicose Vein Treatment 9.2. Deep Vein Thrombosis Treatment 9.3. Lymphedema Treatment 9.4. Other Applications**(use of compression therapy during traveling, pregnancy, foot ulcers, and leg pain) 10. Compression Therapy Market, By Distribution Channel Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 10.1. Pharmacies & Retailers 10.2. Hospitals & Clinics 10.3. E-Commerce Platforms 11. North America Compression Therapy Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028 12. Latin America Compression Therapy Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Europe Compression Therapy Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028 14. Asia Pacific Compression Therapy Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 17.1. Medi GmbH & Co. 17.1.1. Company Overview (HQ, Business Segments, Employee Strength) 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Paul Hartmann AG 17.2.1. Company Overview (HQ, Business Segments, Employee Strength) 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Julius Zorn GmbH 17.3.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. ArjoHuntleigh 17.4.1. Company Overview (HQ, Business Segments, Employee Strength) 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Sigvaris 17.5.1. Company Overview (HQ, Business Segments, Employee Strength) 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Medtronic Plc 17.6.1. Company Overview (HQ, Business Segments, Employee Strength) 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. BSN Medical GmbH 17.7.1. Company Overview (HQ, Business Segments, Employee Strength) 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. DJO Global, Inc. 17.8.1. Company Overview (HQ, Business Segments, Employee Strength) 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Tactile Medical 17.9.1. Company Overview (HQ, Business Segments, Employee Strength) 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10. Sanyleg S.r.l. 17.10.1. Company Overview (HQ, Business Segments, Employee Strength) 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11. 3M Company 17.11.1. Company Overview (HQ, Business Segments, Employee Strength) 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12. ConvaTec Inc. 17.12.1. Company Overview (HQ, Business Segments, Employee Strength) 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Compression Therapy Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Compression Therapy Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Compression Therapy Market Analysis tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Compression Therapy Market, By Technique Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 7.1. Static Compression Therapy 7.2. Dynamic Compression Therapy
8. Compression Therapy Market, By Product Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 8.1. Compression Pumps 8.2. Compression Garments 8.2.1. Compression Stockings 8.2.3. Compression Bandages & Wraps 8.2.4. Other Compression Garments*(foot caps, arm sleeves, gauntlets, compression shirts and bras, chin straps, face masks, and abdominal gloves) 8.3. Compression Braces
9. Compression Therapy Market, By Application Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 9.1. Varicose Vein Treatment 9.2. Deep Vein Thrombosis Treatment 9.3. Lymphedema Treatment 9.4. Other Applications**(use of compression therapy during traveling, pregnancy, foot ulcers, and leg pain)
10. Compression Therapy Market, By Distribution Channel Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 10.1. Pharmacies & Retailers 10.2. Hospitals & Clinics 10.3. E-Commerce Platforms 11. North America Compression Therapy Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Compression Therapy Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Compression Therapy Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Compression Therapy Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 17.1. Medi GmbH & Co. 17.1.1. Company Overview (HQ, Business Segments, Employee Strength) 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Paul Hartmann AG 17.2.1. Company Overview (HQ, Business Segments, Employee Strength) 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Julius Zorn GmbH 17.3.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. ArjoHuntleigh 17.4.1. Company Overview (HQ, Business Segments, Employee Strength) 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Sigvaris 17.5.1. Company Overview (HQ, Business Segments, Employee Strength) 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Medtronic Plc 17.6.1. Company Overview (HQ, Business Segments, Employee Strength) 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. BSN Medical GmbH 17.7.1. Company Overview (HQ, Business Segments, Employee Strength) 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. DJO Global, Inc. 17.8.1. Company Overview (HQ, Business Segments, Employee Strength) 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Tactile Medical 17.9.1. Company Overview (HQ, Business Segments, Employee Strength) 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10. Sanyleg S.r.l. 17.10.1. Company Overview (HQ, Business Segments, Employee Strength) 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11. 3M Company 17.11.1. Company Overview (HQ, Business Segments, Employee Strength) 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12. ConvaTec Inc. 17.12.1. Company Overview (HQ, Business Segments, Employee Strength) 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview
18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics